MESOBLAST LIMITED (ASX:MSB)
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Activity: A biotechnology company in the area of adult stem cell technology.
55 Collins Street Level 39 MELBOURNE VIC 3000
Ph: (03) 9639 6036    Fax: (03) 9639 6030

Executives & Directors

Non Exec. Chairman, Non Exec. Director
Deputy Chairman, Non Exec. Director
Managing Director, CEO
Non Exec. Director
Non Exec. Director
Secretary
Please contact the ASX to change these details

Company Podcasts

Annual General Meeting
Thu, 24 Nov 2011
Full Year Results
Wed, 24 Aug 2011
Interim Results
Mon, 28 Feb 2011
EGM
Wed, 9 Feb 2011
EGM
Wed, 22 Sep 2010
Full Year Results
Thu, 26 Aug 2010
Annual General Meeting
Mon, 30 Nov 2009 11:00am
Full Year Results
Wed, 28 Oct 2009 1:00am
Interim Results
Thu, 26 Feb 2009
Annual General Meeting
Thu, 27 Nov 2008 10:00am
Appendix 3B Thu, 9 Feb 2012
Company Secretary Appointment/Resignation Thu, 9 Feb 2012
FDA Clearance for Phase 2 Clinical Trial in Type 2 Diabetes Tue, 31 Jan 2012
Presentation to 30th JP Morgan Healthcare Conference in USA Thu, 12 Jan 2012
Appendix 3B Thu, 12 Jan 2012
Appendix 4C - quarterly Thu, 12 Jan 2012
FORM 604 NOTICE OF CHANGE OF INTERESTS OF SUB HOLDER Fri, 9 Dec 2011
Chairman`s Address and CEO`s Presentation to Shareholders Thu, 24 Nov 2011
Corporate Strategy Key to Mesoblast`s Success Thu, 24 Nov 2011
Results of Meeting Thu, 24 Nov 2011

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.